National Association for Proton Therapy establishes Physician Advisory Committee

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

To guide the National Association for Proton Therapy, the organization has created a Physician Advisory Committee.

The committee will advise NAPT on critical issues including advancing clinical research collaboration, patient education and equitable insurance reimbursement practices.

Chaired by J. Isabelle Choi, clinical director and research director of the New York Proton Center and Assistant Member at Memorial Sloan Kettering Cancer Center, the committee is comprised of national leaders in radiation oncology and proton therapy including:

  • Gopal Bajaj, Inova Schar Cancer Institute Proton Therapy Center,

  • Brian Baumann, S. Lee Kling Center for Proton Therapy at the Siteman Cancer Center,

  • Jeff Bradley, Emory Proton Therapy Center,

  • Andrew Chang, California Protons Cancer Therapy Center,

  • Steve Frank, MD Anderson Cancer Center Proton Therapy Center,

  • James Gray, Provision CARES Proton Therapy Center,

  • Brandon Gunn, MD Anderson Cancer Center Proton Therapy Center,

  • Nancy Mendenhall, University of Florida Health Proton Therapy Institute,

  • Minesh Mehta, Miami Cancer Institute Proton Therapy Center at Baptist Health South Florida,

  • Charles Simone, New York Proton Center,

  • Christina Tsien, The Johns Hopkins National Proton Center,

  • Torunn Yock, Francis Burr Proton Therapy Center at Massachusetts General Hospital,

  • Jing Zeng, Seattle Cancer Care Alliance Proton Therapy Center.

Under Choi’s leadership, the NAPT Physician Advisory Committee will promote the benefits of proton therapy. The committee will attend advocacy meetings with federal and state government agencies and members of Congress, collaborate with other cancer-related stakeholders, and support proton therapy research.

Previously, Choi was an assistant professor at the University of Maryland School of Medicine and served as a clinical lead of the Maryland Proton Treatment Center.

Table of Contents

YOU MAY BE INTERESTED IN

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.
When it comes to fighting cancer today, collaboration is key. At a time when funding is uncertain, yet innovative breakthroughs are accelerating every day, it’s more important than ever for oncologists, scientists, academic researchers, and community physicians, to come together to share knowledge and gain insights about the forefront of cancer research.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login